{
    "clinical_study": {
        "@rank": "68828", 
        "acronym": "ROTEM-2010", 
        "arm_group": [
            {
                "arm_group_label": "Group C", 
                "arm_group_type": "Active Comparator", 
                "description": "\u2022 conventional protocol, volume replacement with massive bleeding."
            }, 
            {
                "arm_group_label": "Group ROTEM", 
                "arm_group_type": "Experimental", 
                "description": "\u2022 Protocol according to the different tests to be performed with thromboelastography"
            }
        ], 
        "brief_summary": {
            "textblock": "Main objective:\n\n      Determine whether by introducing thromboelastograph, the investigators reduced the number of\n      packed red cells received by each patient (median) compared to the usual protocol, in which\n      the indication for transfusion is based on laboratory tests: Prothrombin time, time\n      activated partial thromboplastin time, thrombin, reptilase, fibrinogen and platelet contage.\n\n      Design:\n\n      Prospective randomized controlled trial and single blinded.\n\n      Disease or disorder under study:\n\n      Study of coagulopathy in patients undergoing cardiac surgery with cardiopulmonary bypass\n      (CPB).\n\n      Primary endpoint:\n\n      median transfusion of packed red blood cells per patient. Study population Male and female\n      patients over 18 years undergoing cardiac surgery with cardiopulmonary bypass to bleed\n      excessively.\n\n      Duration of treatment:\n\n      The coagulation monitoring methods tested are made from protamine administration to CEC\n      output if a) the patient bleeds diffusely, or b) from arrival in the unit if not satisfied\n      critics a) bleed excessively drains and until the patient stops bleeding (debit drains <a\n      150ml / h)."
        }, 
        "brief_title": "Blood Products Transfusion in Cardiac Surgery After the Implementation of a Coagulation Monitoring System at Patient Bedside: Thromboelastometry Versus Standard Transfusion Protocol", 
        "completion_date": {
            "#text": "September 2011", 
            "@type": "Actual"
        }, 
        "condition": "Hemostatic Disorders", 
        "condition_browse": {
            "mesh_term": [
                "Hemostatic Disorders", 
                "Blood Coagulation Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female patients\n\n          -  over 18 years\n\n          -  undergoing cardiac surgery\n\n          -  with cardiopulmonary bypass\n\n          -  bleed excessively\n\n        As it is not possible to predict in advance who will bleed, informed consent will be\n        required for all patients over 18 who are to undergo cardiac surgery with CPB.\n\n        Will be randomized to either group\n\n          1. Those patients with diffuse bleeding after protamine administration. and / or\n\n          2. They bleed excessively after surgery. Are excessive bleeding criteria: the debit \u2265\n             300ml drains in the first hour; \u2265 250ml in the second hour or \u2265 150ml at any later\n             time. Consider that the patient is bleeding excessively when the drains debit is\n             <150ml.\n\n        Exclusion Criteria:\n\n          -  Patients <18 years\n\n          -  Extracorporeal circulation surgery\n\n          -  Surgery with Mini extracorporeal circulation (MECC)\n\n          -  Refuse to participate in the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "49", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01919840", 
            "org_study_id": "IIBSP-ROT-2010-15"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group ROTEM", 
                "description": "10 min after administration of protamine, if there is a large diffuse microvascular bleeding or bleed excessively at the exit of surgery then will check an Intem, a Heptem a Extem and Fibtem.\nIf any of the determinations altered and the patient leaves still bleeding apply the proposed treatment algorithm for Rotem. 10 minutes after each treatment will take the test again indicated that treatment, to ensure that the defect has been corrected.", 
                "intervention_name": "Group ROTEM", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Group C", 
                "description": "10 min. after protamine administration, if there is a significant diffuse microvascular bleeding or when the patient departure from surgery if bleeds excessively will be a TCA and routed the following analytical results: prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen.\nIf any of the determinations altered and the patient still bleeding, apply the standard protocol of the unit. 10 minutes after each treatment was performed new laboratory tests to analyze the result.", 
                "intervention_name": "Group C", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "hemostatic disorders", 
            "ardiac surgery", 
            "cardiopulmonary bypass"
        ], 
        "lastchanged_date": "August 8, 2013", 
        "number_of_arms": "2", 
        "official_title": "Indicaci\u00f3n de transfusi\u00f3n de Hemoderivados en el Postoperatorio de cirug\u00eda Cardiaca Tras la implantaci\u00f3n de un Sistema de monitorizaci\u00f3n de la coagulaci\u00f3n a la Cabecera Del Paciente: Tromboelastometr\u00eda Versus Protocolo Habitual de transfusi\u00f3n", 
        "overall_official": {
            "affiliation": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
            "last_name": "Pilar Paniagua, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "median transfusion of packed red cells per patient", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01919840"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "rate transfusion of platelets pool and plasma pool", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "source": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2013", 
        "why_stopped": "Low recruitment after the expected time to finish the study"
    }
}